US Stock MarketDetailed Quotes

ALNAQ Allena Pharmaceuticals

Watchlist

0.000
0.0000.00%

15min DelayTrading Dec 14 09:30 ET

122.08Market Cap0.00P/E (TTM)

Allena Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

(Q3)Sep 30, 2021

(Q2)Jun 30, 2021

(Q1)Mar 31, 2021

(FY)Dec 31, 2020

(Q4)Dec 31, 2020

(Q3)Sep 30, 2020

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

59.89%-4.56M

-99.65%-20.04M

-62.21%-45.68M

-63.51%-12.8M

-127.45%-11.48M

-68.95%-11.36M

-17.27%-10.04M

35.46%-28.16M

34.34%-7.83M

44.37%-5.05M

Net income from continuing operations

39.63%-8.44M

-1.52%-11.81M

-48.16%-48.66M

-1.02%-10.36M

-58.14%-12.69M

-100.29%-13.97M

-53.41%-11.64M

30.62%-32.85M

9.69%-10.26M

39.60%-8.03M

Operating gains losses

----

228.57%9K

--0

----

---7K

----

Depreciation and amortization

47.50%118K

92.31%125K

118.67%363K

183.72%122K

140.00%96K

90.48%80K

58.54%65K

1.84%166K

2.38%43K

-4.76%40K

Other non cash items

-17.60%103K

50.00%138K

-33.07%425K

-51.40%104K

-30.20%104K

-11.97%125K

-29.23%92K

28.54%635K

79.83%214K

19.20%149K

Change In working capital

17.85%1.7M

-1,680.56%-9.1M

-832.70%-1.48M

-375.14%-3.48M

-101.72%-29K

255.21%1.45M

126.43%576K

-360.66%-159K

183.92%1.26M

-47.90%1.69M

-Change in prepaid assets

151.34%1.41M

-48,629.41%-8.28M

-198.78%-811K

-44.88%-1.49M

-82.19%132K

42.24%559K

-102.39%-17K

506.44%821K

-18.09%-1.03M

-52.68%741K

-Change in payables and accrued expense

-63.24%372K

-211.09%-741K

20.68%-372K

-180.40%-1.92M

-111.57%-131K

185.62%1.01M

123.76%667K

-169.90%-469K

603.80%2.39M

-37.01%1.13M

-Change in other current assets

----

--0

-90.00%5K

190.00%45K

----

--0

--50K

---50K

-Change in other current liabilities

2.63%-74K

-6.76%-79K

41.29%-300K

50.00%-75K

44.44%-75K

46.48%-76K

11.90%-74K

3.77%-511K

7.98%-150K

-9.76%-135K

Cash from discontinued investing activities

Operating cash flow

59.89%-4.56M

-99.65%-20.04M

-62.21%-45.68M

-63.51%-12.8M

-127.45%-11.48M

-68.95%-11.36M

-17.27%-10.04M

35.46%-28.16M

34.34%-7.83M

44.37%-5.05M

Investing cash flow

Cash flow from continuing investing activities

-5.54%-667K

96.04%-25K

-185K

-35K

-422K

-418.03%-632K

-632K

Net PPE purchase and sale

--0

-5.54%-667K

96.04%-25K

---185K

---35K

---422K

-418.03%-632K

---632K

--0

Cash from discontinued investing activities

Investing cash flow

--0

-5.54%-667K

96.04%-25K

---185K

---35K

---422K

-418.03%-632K

---632K

--0

Financing cash flow

Cash flow from continuing financing activities

27.46%2.25M

-109.02%-1.06M

22.07%41.29M

-82.08%2.4M

191.29%25.43M

-86.12%1.77M

1,272.65%11.7M

179.14%33.83M

431.95%13.37M

72,841.67%8.73M

Net issuance payments of debt

--0

---5M

--0

--2M

Net common stock issuance

--0

-66.30%3.94M

21.41%41.27M

-82.43%2.38M

277.42%25.43M

-87.15%1.76M

--11.7M

182.47%34M

447.58%13.56M

67,470.00%6.74M

Proceeds from stock option exercised by employees

----

-73.91%18K

-45.83%13K

--0

----

-38.39%69K

-45.45%24K

--0

Net other financing activities

----

-720.69%-238K

-2,957.14%-214K

0.00%-8K

Cash from discontinued financing activities

Financing cash flow

27.46%2.25M

-109.02%-1.06M

22.07%41.29M

-82.08%2.4M

191.29%25.43M

-86.12%1.77M

1,272.65%11.7M

179.14%33.83M

431.95%13.37M

72,841.67%8.73M

Net cash flow

Beginning cash position

-75.49%8.9M

-14.42%29.99M

16.78%35.04M

34.13%40.42M

0.77%26.66M

77.43%36.29M

16.78%35.04M

-51.32%30.01M

-23.55%30.14M

-45.48%26.45M

Current changes in cash

76.06%-2.31M

-1,794.22%-21.09M

-200.38%-5.05M

-312.66%-10.43M

273.74%13.77M

-260.46%-9.63M

113.03%1.25M

115.92%5.04M

152.12%4.91M

140.45%3.68M

End cash Position

-75.28%6.59M

-75.49%8.9M

-14.42%29.99M

34.13%40.42M

0.77%26.66M

77.43%36.29M

16.78%35.04M

-23.55%30.14M

Free cash flow

60.02%-4.56M

-91.59%-20.04M

-60.87%-46.35M

-51.27%-12.83M

-131.11%-11.66M

-69.47%-11.4M

-22.20%-10.46M

34.16%-28.81M

28.89%-8.48M

44.50%-5.05M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021	(Q3)Sep 30, 2021	(Q2)Jun 30, 2021	(Q1)Mar 31, 2021	(FY)Dec 31, 2020	(Q4)Dec 31, 2020	(Q3)Sep 30, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	59.89%-4.56M	-99.65%-20.04M	-62.21%-45.68M	-63.51%-12.8M	-127.45%-11.48M	-68.95%-11.36M	-17.27%-10.04M	35.46%-28.16M	34.34%-7.83M	44.37%-5.05M
Net income from continuing operations	39.63%-8.44M	-1.52%-11.81M	-48.16%-48.66M	-1.02%-10.36M	-58.14%-12.69M	-100.29%-13.97M	-53.41%-11.64M	30.62%-32.85M	9.69%-10.26M	39.60%-8.03M
Operating gains losses	----	----	228.57%9K	--0	----	----	----	---7K	----	----
Depreciation and amortization	47.50%118K	92.31%125K	118.67%363K	183.72%122K	140.00%96K	90.48%80K	58.54%65K	1.84%166K	2.38%43K	-4.76%40K
Other non cash items	-17.60%103K	50.00%138K	-33.07%425K	-51.40%104K	-30.20%104K	-11.97%125K	-29.23%92K	28.54%635K	79.83%214K	19.20%149K
Change In working capital	17.85%1.7M	-1,680.56%-9.1M	-832.70%-1.48M	-375.14%-3.48M	-101.72%-29K	255.21%1.45M	126.43%576K	-360.66%-159K	183.92%1.26M	-47.90%1.69M
-Change in prepaid assets	151.34%1.41M	-48,629.41%-8.28M	-198.78%-811K	-44.88%-1.49M	-82.19%132K	42.24%559K	-102.39%-17K	506.44%821K	-18.09%-1.03M	-52.68%741K
-Change in payables and accrued expense	-63.24%372K	-211.09%-741K	20.68%-372K	-180.40%-1.92M	-111.57%-131K	185.62%1.01M	123.76%667K	-169.90%-469K	603.80%2.39M	-37.01%1.13M
-Change in other current assets	----	----	--0	-90.00%5K	190.00%45K	----	----	--0	--50K	---50K
-Change in other current liabilities	2.63%-74K	-6.76%-79K	41.29%-300K	50.00%-75K	44.44%-75K	46.48%-76K	11.90%-74K	3.77%-511K	7.98%-150K	-9.76%-135K
Cash from discontinued investing activities
Operating cash flow	59.89%-4.56M	-99.65%-20.04M	-62.21%-45.68M	-63.51%-12.8M	-127.45%-11.48M	-68.95%-11.36M	-17.27%-10.04M	35.46%-28.16M	34.34%-7.83M	44.37%-5.05M
Investing cash flow
Cash flow from continuing investing activities	0	0	-5.54%-667K	96.04%-25K	-185K	-35K	-422K	-418.03%-632K	-632K	0
Net PPE purchase and sale	--0	--0	-5.54%-667K	96.04%-25K	---185K	---35K	---422K	-418.03%-632K	---632K	--0
Cash from discontinued investing activities
Investing cash flow	--0	--0	-5.54%-667K	96.04%-25K	---185K	---35K	---422K	-418.03%-632K	---632K	--0
Financing cash flow
Cash flow from continuing financing activities	27.46%2.25M	-109.02%-1.06M	22.07%41.29M	-82.08%2.4M	191.29%25.43M	-86.12%1.77M	1,272.65%11.7M	179.14%33.83M	431.95%13.37M	72,841.67%8.73M
Net issuance payments of debt	--0	---5M	--0	--0	--0	--0	--0	--0	--0	--2M
Net common stock issuance	--0	-66.30%3.94M	21.41%41.27M	-82.43%2.38M	277.42%25.43M	-87.15%1.76M	--11.7M	182.47%34M	447.58%13.56M	67,470.00%6.74M
Proceeds from stock option exercised by employees	----	----	-73.91%18K	-45.83%13K	--0	----	----	-38.39%69K	-45.45%24K	--0
Net other financing activities	----	----	----	----	----	----	----	-720.69%-238K	-2,957.14%-214K	0.00%-8K
Cash from discontinued financing activities
Financing cash flow	27.46%2.25M	-109.02%-1.06M	22.07%41.29M	-82.08%2.4M	191.29%25.43M	-86.12%1.77M	1,272.65%11.7M	179.14%33.83M	431.95%13.37M	72,841.67%8.73M
Net cash flow
Beginning cash position	-75.49%8.9M	-14.42%29.99M	16.78%35.04M	34.13%40.42M	0.77%26.66M	77.43%36.29M	16.78%35.04M	-51.32%30.01M	-23.55%30.14M	-45.48%26.45M
Current changes in cash	76.06%-2.31M	-1,794.22%-21.09M	-200.38%-5.05M	-312.66%-10.43M	273.74%13.77M	-260.46%-9.63M	113.03%1.25M	115.92%5.04M	152.12%4.91M	140.45%3.68M
End cash Position	-75.28%6.59M	-75.49%8.9M	-14.42%29.99M	-14.42%29.99M	34.13%40.42M	0.77%26.66M	77.43%36.29M	16.78%35.04M	16.78%35.04M	-23.55%30.14M
Free cash flow	60.02%-4.56M	-91.59%-20.04M	-60.87%-46.35M	-51.27%-12.83M	-131.11%-11.66M	-69.47%-11.4M	-22.20%-10.46M	34.16%-28.81M	28.89%-8.48M	44.50%-5.05M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data